Schering Moves Forward On GMP Work Plan; Is Marketing Settlement Next?
Executive Summary
An agreement between FDA and Schering-Plough over the company's GMP work plan is the first tangible sign that CEO Fred Hassan is delivering on his pledge to resolve outstanding legal issues as quickly as possible
You may also be interested in...
Lilly Revisits Priorities: GMPs Awarded Same Status As R&D, Marketing
Lilly is rearranging its operating priorities to put manufacturing processes on the same level as R&D and sales and marketing, CEO Sidney Taurel told investors
Lilly Revisits Priorities: GMPs Awarded Same Status As R&D, Marketing
Lilly is rearranging its operating priorities to put manufacturing processes on the same level as R&D and sales and marketing, CEO Sidney Taurel told investors
Schering-Plough Faces Criminal Case; Off-Label Promotion May Be One Count
A criminal investigation of Schering-Plough's marketing practices includes off-label promotion, the company disclosed May 30